Potential rapid intraoperative cancer diagnosis using dynamic full-field optical coherence tomography and deep learning: A prospective cohort study in breast cancer patients.

Journal: Science bulletin
PMID:

Abstract

An intraoperative diagnosis is critical for precise cancer surgery. However, traditional intraoperative assessments based on hematoxylin and eosin (H&E) histology, such as frozen section, are time-, resource-, and labor-intensive, and involve specimen-consuming concerns. Here, we report a near-real-time automated cancer diagnosis workflow for breast cancer that combines dynamic full-field optical coherence tomography (D-FFOCT), a label-free optical imaging method, and deep learning for bedside tumor diagnosis during surgery. To classify the benign and malignant breast tissues, we conducted a prospective cohort trial. In the modeling group (n = 182), D-FFOCT images were captured from April 26 to June 20, 2018, encompassing 48 benign lesions, 114 invasive ductal carcinoma (IDC), 10 invasive lobular carcinoma, 4 ductal carcinoma in situ (DCIS), and 6 rare tumors. Deep learning model was built up and fine-tuned in 10,357 D-FFOCT patches. Subsequently, from June 22 to August 17, 2018, independent tests (n = 42) were conducted on 10 benign lesions, 29 IDC, 1 DCIS, and 2 rare tumors. The model yielded excellent performance, with an accuracy of 97.62%, sensitivity of 96.88% and specificity of 100%; only one IDC was misclassified. Meanwhile, the acquisition of the D-FFOCT images was non-destructive and did not require any tissue preparation or staining procedures. In the simulated intraoperative margin evaluation procedure, the time required for our novel workflow (approximately 3 min) was significantly shorter than that required for traditional procedures (approximately 30 min). These findings indicate that the combination of D-FFOCT and deep learning algorithms can streamline intraoperative cancer diagnosis independently of traditional pathology laboratory procedures.

Authors

  • Shuwei Zhang
    State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116024, China. Electronic address: zswei@dlut.edu.cn.
  • Bin Yang
    School of Control Science and Engineering, Dalian University of Technology, Dalian 116024, PR China. Electronic address: yangbin@dlut.edu.cn.
  • Houpu Yang
    Breast Center, Peking University People's Hospital, Beijing 100044, China.
  • Jin Zhao
    Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, 36 Lazi East Road, Tianfu New Area, Chengdu, 610000, China.
  • Yuanyuan Zhang
    National Clinical Research Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Yuanxu Gao
    Institute for AI in Medicine and Faculty of Medicine, Macau University of Science and Technology, Macau, China; State Key Laboratory of Eye Health, Eye Hospital and Institute for Advanced Study on Eye Health and Diseases, Wenzhou Medical University, Wenzhou, China; National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China; Department of Big Data and Biomedical AI, College of Future Technology, Peking University and Peking-Tsinghua Center for Life Sciences, Beijing, China.
  • Olivia Monteiro
    Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Macao 999078, China.
  • Kang Zhang
    Xifeng District People's Hospital, Qingyang, China.
  • Bo Liu
    Wuhan United Imaging Healthcare Surgical Technology Co., Ltd., Wuhan, China.
  • Shu Wang
    Department of Radiology, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, Jiangsu, China.